Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study

To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using stati...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 16; no. 10; p. e0259153
Main Authors Yeh, Jun-Jun, Lin, Cheng-Li, Hsu, Nai-Hua, Kao, Chia-Hung
Format Journal Article
LanguageEnglish
Published San Francisco Public Library of Science 27.10.2021
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
AbstractList To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). Methods We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Results Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. Conclusions The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). Methods We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Results Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65–0.79) and 0.52 (0.38–0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65–0.79)/0.69 (0.61–0.79) and 0.54 (0.39–0.74)/0.50 (0.32–0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42–1.18)/0.74 (0.64–0.85) and 0.23 (0.03–1.59)/0.54 (0.35–0.85), respectively. Conclusions The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).PURPOSETo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.METHODSWe retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.RESULTSCompared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.CONCLUSIONSThe findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
PurposeTo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).MethodsWe retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.ResultsCompared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.ConclusionsThe findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.
Audience Academic
Author Yeh, Jun-Jun
Hsu, Nai-Hua
Lin, Cheng-Li
Kao, Chia-Hung
AuthorAffiliation 2 China medical university, Taichung, Taiwan
Universitaria di Bologna, ITALY
3 Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan
7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan
6 Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
8 Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan
5 Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan
1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan
4 College of Medicine, China Medical University, Taichung, Taiwan
AuthorAffiliation_xml – name: Universitaria di Bologna, ITALY
– name: 1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan
– name: 8 Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan
– name: 4 College of Medicine, China Medical University, Taichung, Taiwan
– name: 7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan
– name: 2 China medical university, Taichung, Taiwan
– name: 3 Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan
– name: 5 Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan
– name: 6 Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
Author_xml – sequence: 1
  givenname: Jun-Jun
  orcidid: 0000-0002-4368-7880
  surname: Yeh
  fullname: Yeh, Jun-Jun
– sequence: 2
  givenname: Cheng-Li
  surname: Lin
  fullname: Lin, Cheng-Li
– sequence: 3
  givenname: Nai-Hua
  surname: Hsu
  fullname: Hsu, Nai-Hua
– sequence: 4
  givenname: Chia-Hung
  orcidid: 0000-0002-6368-3676
  surname: Kao
  fullname: Kao, Chia-Hung
BookMark eNqNk2uL1DAUhousuBf9B4IFQfTDjOklabofhGFZdWBhwdvXkObSyZpJapOq83v8o57OdGG7LCL90PLmed_knJ6cJkfOO5UkzzO0zIoqe3vjh95xu-xAXqIc1xkuHiUnWV3kC5Kj4ujO93FyGsINQrighDxJjouyQpji7CT5c6m1EjGkXqch8mhcSLmT8K16byToLhW-9473u5T3oO5SaYLiQU1c77-r1Li0A7NykPTLxA0IgIZoouE2tYNrZ65usNtDpDZN74MJ5-kqbZVTPeCdh3VIg61DHOTuafJYcxvUs-l9lnx9f_nl4uPi6vrD-mJ1tRCE1HFBSEOF1pIShWoqm4biWqIyV2WVlbIWtEAa9AoBl40rNVakqTSRsgGJFmfJi0NuZ31gU38DyzElNUUFGYn1gZCe37CuN1uogXlu2F7wfcugR0ZYxbhCpKQoK3WNykbTWuQ4IzLL80IQTgRkvZt2G5qtkgJ6B8XPQucrzmxY638yijEqCwIBr6eA3v8YVIhsa4JQ1nKn_LA_d1XhvKwrQF_eQx-ubqJaDgUYpz3sK8ZQtiKA0IpgBNTyAQoeqbZGwDBqA_rM8GZmACaq37HlQwhs_fnT_7PX3-bsqzvsRnEbN8HbYRycMAfPD6CAUQu90kyYuJ8vOLmxLENsvFG3PWHjjWLTjQJzec98-4f-afsLZLEpWQ
CitedBy_id crossref_primary_10_1186_s40001_024_01836_1
crossref_primary_10_3390_metabo14060292
crossref_primary_10_3390_biomedicines10061290
crossref_primary_10_3389_fcvm_2022_925211
crossref_primary_10_3389_fcvm_2022_797623
Cites_doi 10.1001/jamainternmed.2020.0994
10.1093/eurheartj/ehaa231
10.1186/1472-6963-13-152
10.1016/j.chest.2019.04.015
10.1093/ehjcvp/pvaa042
10.1016/j.chest.2017.03.033
10.1002/pds.2338
10.1136/annrheumdis-2020-217442
10.3906/sag-2004-168
10.1016/S0140-6736(10)62174-5
10.1183/13993003.02419-2016
10.1183/09059180.00000713
10.1002/pds.3864
10.1038/cddis.2017.260
10.1161/JAHA.118.011320
10.1378/chest.14-3138
10.1016/j.rmed.2011.03.020
10.1056/NEJMc2015630
10.2188/jea.JE20140076
10.1038/s41598-020-74492-0
10.1513/AnnalsATS.201610-764OC
10.2147/CLEP.S196293
10.1016/j.chest.2019.10.032
10.1007/s11892-019-1178-6
10.1016/j.jfma.2013.09.009
10.1186/s12906-018-2384-5
10.1128/mBio.00398-20
10.1136/thoraxjnl-2016-208819
10.1016/j.jacc.2018.02.006
10.3389/fmed.2020.00170
10.1152/ajplung.00344.2017
10.1371/journal.pone.0140571
10.1183/16000617.0077-2018
10.1111/ijcp.14066
10.3389/fpsyt.2019.00103
10.1016/j.rmed.2012.07.012
10.1136/thx.2004.030205
ContentType Journal Article
Copyright COPYRIGHT 2021 Public Library of Science
2021 Yeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 Yeh et al 2021 Yeh et al
Copyright_xml – notice: COPYRIGHT 2021 Public Library of Science
– notice: 2021 Yeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 Yeh et al 2021 Yeh et al
DBID AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0259153
DatabaseName CrossRef
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
Coronavirus Research Database
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList




MEDLINE - Academic

Agricultural Science Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Effects of statins and steroids on CAD and stroke among patients with ILD-PF
EISSN 1932-6203
ExternalDocumentID 2586980368
oai_doaj_org_article_ae0648014f904bf89c2516d1223c6a6c
PMC8550436
A680387650
10_1371_journal_pone_0259153
GeographicLocations Taiwan
China
GeographicLocations_xml – name: Taiwan
– name: China
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: MOHW110-TDU-B-212-124004
– fundername: ;
  grantid: CMU107-ASIA-19, DMR-109-231
– fundername: ;
  grantid: MOST 108-2321-B-039-003
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c669t-66b8cffd86e098dbb859d042e4714d9c830f98d706b819d0495e6b7f6ddb6b883
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:11:54 EST 2021
Wed Aug 27 01:22:59 EDT 2025
Thu Aug 21 14:20:56 EDT 2025
Fri Jul 11 05:37:52 EDT 2025
Fri Jul 25 11:25:54 EDT 2025
Tue Jun 17 21:36:12 EDT 2025
Tue Jun 10 20:46:01 EDT 2025
Fri Jun 27 05:02:02 EDT 2025
Fri Jun 27 04:17:26 EDT 2025
Thu May 22 21:23:24 EDT 2025
Tue Jul 01 03:58:58 EDT 2025
Thu Apr 24 22:53:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c669t-66b8cffd86e098dbb859d042e4714d9c830f98d706b819d0495e6b7f6ddb6b883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-4368-7880
0000-0002-6368-3676
OpenAccessLink https://doaj.org/article/ae0648014f904bf89c2516d1223c6a6c
PMID 34705851
PQID 2586980368
PQPubID 1436336
PageCount e0259153
ParticipantIDs plos_journals_2586980368
doaj_primary_oai_doaj_org_article_ae0648014f904bf89c2516d1223c6a6c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8550436
proquest_miscellaneous_2587752497
proquest_journals_2586980368
gale_infotracmisc_A680387650
gale_infotracacademiconefile_A680387650
gale_incontextgauss_ISR_A680387650
gale_incontextgauss_IOV_A680387650
gale_healthsolutions_A680387650
crossref_citationtrail_10_1371_journal_pone_0259153
crossref_primary_10_1371_journal_pone_0259153
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-27
PublicationDateYYYYMMDD 2021-10-27
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-27
  day: 27
PublicationDecade 2020
PublicationPlace San Francisco
PublicationPlace_xml – name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationYear 2021
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References MJ Ko (pone.0259153.ref025) 2019; 8
B Duchemann (pone.0259153.ref027) 2017; 50
CK Wu (pone.0259153.ref022) 2018; 71
N Veronese (pone.0259153.ref038) 2020; 7
Heart Protection Study Collaborative G (pone.0259153.ref036) 2011; 377
C Wu (pone.0259153.ref004) 2020; 180
SS Chang (pone.0259153.ref024) 2021; 75
CC Lai (pone.0259153.ref020) 2012; 106
B Ley (pone.0259153.ref018) 2017; 14
MS Ali (pone.0259153.ref034) 2016; 25
YJI Lee (pone.0259153.ref003) 2017; 8
Y Nan-Ping (pone.0259153.ref031) 2013; 13
M Kreuter (pone.0259153.ref005) 2019; 156
TY Xiong (pone.0259153.ref006) 2020; 41
SW Kim (pone.0259153.ref011) 2019; 10
PD Rosenblit (pone.0259153.ref021) 2019; 19
B. Southern (pone.0259153.ref040) 2020
AW Wong (pone.0259153.ref007) 2020; 158
N Azadeh (pone.0259153.ref017) 2017; 152
DS Fedson (pone.0259153.ref014) 2020; 11
MD Solomon (pone.0259153.ref010) 2020; 383
K Maneechotesuwan (pone.0259153.ref002) 2015; 148
CY Hsieh (pone.0259153.ref033) 2015; 114
C Mihai (pone.0259153.ref039) 2020; 79
L Todorova (pone.0259153.ref037) 2011; 105
A Tufan (pone.0259153.ref009) 2020; 50
N Jones (pone.0259153.ref019) 2012; 21
MY Wu (pone.0259153.ref028) 2018; 18
CL Cheng (pone.0259153.ref023) 2014; 24
YH Li (pone.0259153.ref016) 2013; 10
PL Molyneaux (pone.0259153.ref030) 2013; 22
SJ Gurczynski (pone.0259153.ref001) 2018; 314
G Sheng (pone.0259153.ref008) 2020; 157
M Kreuter (pone.0259153.ref015) 2017; 72
CY Hsieh (pone.0259153.ref032) 2019; 11
DS Hui (pone.0259153.ref029) 2005; 60
S Vedel-Krogh (pone.0259153.ref035) 2015; 10
WYT Tan (pone.0259153.ref012) 2020; 10
V Castiglione (pone.0259153.ref013) 2020; 6
AL Olson (pone.0259153.ref026) 2018; 27
References_xml – volume: 180
  start-page: 934
  issue: 7
  year: 2020
  ident: pone.0259153.ref004
  article-title: Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan
  publication-title: China. JAMA Intern Med
  doi: 10.1001/jamainternmed.2020.0994
– volume: 41
  start-page: 1798
  issue: 19
  year: 2020
  ident: pone.0259153.ref006
  article-title: Coronaviruses and the cardiovascular system: acute and long-term implications
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehaa231
– volume: 158
  start-page: 1069
  issue: 3
  year: 2020
  ident: pone.0259153.ref007
  article-title: Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the COVID-19 Pandemic
  publication-title: Chest
– volume: 13
  start-page: 152
  issue: 1
  year: 2013
  ident: pone.0259153.ref031
  article-title: Comparisons of medical utilizations and categorical diagnoses of emergency visits between the elderly with catastrophic illness certificates and those without
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-13-152
– volume: 156
  start-page: 706
  issue: 4
  year: 2019
  ident: pone.0259153.ref005
  article-title: Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.
  publication-title: Chest
  doi: 10.1016/j.chest.2019.04.015
– volume: 6
  start-page: 258
  issue: 4
  year: 2020
  ident: pone.0259153.ref013
  article-title: Statin therapy in COVID-19 infection
  publication-title: Eur Heart J Cardiovasc Pharmacother
  doi: 10.1093/ehjcvp/pvaa042
– volume: 152
  start-page: 842
  issue: 4
  year: 2017
  ident: pone.0259153.ref017
  article-title: The Role of Infection in Interstitial Lung Diseases
  publication-title: A Review. CHEST
  doi: 10.1016/j.chest.2017.03.033
– volume: 21
  start-page: 256
  issue: S1
  year: 2012
  ident: pone.0259153.ref019
  article-title: A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.2338
– volume: 79
  start-page: 668
  issue: 5
  year: 2020
  ident: pone.0259153.ref039
  article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-217442
– volume: 50
  start-page: 620
  issue: Si-1
  year: 2020
  ident: pone.0259153.ref009
  article-title: COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
  publication-title: Turk J Med Sci
  doi: 10.3906/sag-2004-168
– volume: 377
  start-page: 469
  issue: 9764
  year: 2011
  ident: pone.0259153.ref036
  article-title: C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20536 patients in the Heart Protection Study
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(10)62174-5
– volume: 50
  start-page: 1602419
  issue: 2
  year: 2017
  ident: pone.0259153.ref027
  article-title: Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02419-2016
– volume: 22
  start-page: 376
  issue: 129
  year: 2013
  ident: pone.0259153.ref030
  article-title: The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.
  publication-title: Eur Respir Rev
  doi: 10.1183/09059180.00000713
– volume: 25
  start-page: 114
  issue: Suppl 1
  year: 2016
  ident: pone.0259153.ref034
  article-title: Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.3864
– volume: 8
  start-page: e2860
  issue: 6
  year: 2017
  ident: pone.0259153.ref003
  article-title: Simvastatin treatment boosts benefits of apoptotic cell infusion in murine lung fibrosis
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.260
– volume: 8
  start-page: e011320
  issue: 8
  year: 2019
  ident: pone.0259153.ref025
  article-title: Time and Dose Dependent Association of Statin Use With Risk of Clinically Relevant NewOnset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.011320
– volume: 148
  start-page: 1164
  issue: 5
  year: 2015
  ident: pone.0259153.ref002
  article-title: Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD
  publication-title: Chest
  doi: 10.1378/chest.14-3138
– volume: 105
  start-page: 1296
  issue: 9
  year: 2011
  ident: pone.0259153.ref037
  article-title: TGFβ2-induced matrix production by bronchial fibroblasts in asthma: Budesonide and formoterol effects
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2011.03.020
– volume: 10
  start-page: 151
  issue: 2
  year: 2013
  ident: pone.0259153.ref016
  article-title: Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats
  publication-title: J Geriatr Cardiol
– volume: 383
  start-page: 691
  issue: 7
  year: 2020
  ident: pone.0259153.ref010
  article-title: The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc2015630
– volume: 24
  start-page: 500
  issue: 6
  year: 2014
  ident: pone.0259153.ref023
  article-title: Validation of acute myocardial infarction cases in the national health insurance research database in taiwan
  publication-title: J Epidemiol
  doi: 10.2188/jea.JE20140076
– volume: 10
  start-page: 17458
  issue: 1
  year: 2020
  ident: pone.0259153.ref012
  article-title: Statin use is associated with lower disease severity in COVID-19 infection
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-74492-0
– year: 2020
  ident: pone.0259153.ref040
  article-title: Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.
  publication-title: Cleve Clin J Med
– volume: 14
  start-page: 880
  issue: 6
  year: 2017
  ident: pone.0259153.ref018
  article-title: Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.201610-764OC
– volume: 11
  start-page: 349
  year: 2019
  ident: pone.0259153.ref032
  article-title: Taiwan’s National Health Insurance Research Database: past and future
  publication-title: Clin Epidemiol
  doi: 10.2147/CLEP.S196293
– volume: 157
  start-page: 1175
  issue: 5
  year: 2020
  ident: pone.0259153.ref008
  article-title: Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis
  publication-title: Chest
  doi: 10.1016/j.chest.2019.10.032
– volume: 19
  start-page: 61
  issue: 8
  year: 2019
  ident: pone.0259153.ref021
  article-title: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-019-1178-6
– volume: 114
  start-page: 254
  issue: 3
  year: 2015
  ident: pone.0259153.ref033
  article-title: Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database
  publication-title: J Formos Med Assoc
  doi: 10.1016/j.jfma.2013.09.009
– volume: 18
  start-page: 341
  issue: 1
  year: 2018
  ident: pone.0259153.ref028
  article-title: Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study
  publication-title: BMC Complement Altern Med
  doi: 10.1186/s12906-018-2384-5
– volume: 11
  start-page: e00398
  issue: 2
  year: 2020
  ident: pone.0259153.ref014
  article-title: Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
  publication-title: mBio.
  doi: 10.1128/mBio.00398-20
– volume: 72
  start-page: 148
  issue: 2
  year: 2017
  ident: pone.0259153.ref015
  article-title: Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
  publication-title: Thorax.
  doi: 10.1136/thoraxjnl-2016-208819
– volume: 71
  start-page: 1273
  issue: 11
  year: 2018
  ident: pone.0259153.ref022
  article-title: The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2018.02.006
– volume: 7
  start-page: 170
  year: 2020
  ident: pone.0259153.ref038
  article-title: Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2020.00170
– volume: 314
  start-page: L6
  issue: 1
  year: 2018
  ident: pone.0259153.ref001
  article-title: IL-17 in the lung: the good, the bad, and the ugly
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00344.2017
– volume: 10
  start-page: e0140571
  issue: 10
  year: 2015
  ident: pone.0259153.ref035
  article-title: Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease
  publication-title: PloS one
  doi: 10.1371/journal.pone.0140571
– volume: 27
  start-page: 180077
  issue: 150
  year: 2018
  ident: pone.0259153.ref026
  article-title: The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
  publication-title: Eur Respir Rev
  doi: 10.1183/16000617.0077-2018
– volume: 75
  start-page: e14066
  issue: 5
  year: 2021
  ident: pone.0259153.ref024
  article-title: Sex differences in long-term cardiovascular outcomes among patients with acute myocardial infarction: A population-based retrospective cohort study
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.14066
– volume: 10
  start-page: 103
  year: 2019
  ident: pone.0259153.ref011
  article-title: Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2019.00103
– volume: 106
  start-page: 1566
  issue: 11
  year: 2012
  ident: pone.0259153.ref020
  article-title: Idiopathic pulmonary fibrosis in Taiwan–A population-based study
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2012.07.012
– volume: 60
  start-page: 401
  issue: 5
  year: 2005
  ident: pone.0259153.ref029
  article-title: Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
  publication-title: Thorax
  doi: 10.1136/thx.2004.030205
SSID ssj0053866
Score 2.4001765
Snippet Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and...
To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and...
PurposeTo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and...
Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage e0259153
SubjectTerms Angina pectoris
Biology and Life Sciences
Cardiovascular disease
Care and treatment
Chronology
Codes
Complications and side effects
Confidence intervals
Consent
Coronary artery
Coronary artery disease
Coronary heart disease
Coronary vessels
Corticoids
Corticosteroids
Diabetes
Fibrosis
Health insurance
Health risks
Heart attacks
Heart diseases
Hospitals
Hypertension
Infections
Ischemia
Kidney diseases
Lung diseases
Medical research
Medicine and Health Sciences
Mortality
Patient outcomes
Physical Sciences
Population studies
Population-based studies
Pulmonary fibrosis
Rheumatism
Sleep disorders
Software
Statins
Statistical analysis
Steroid hormones
Steroids
Steroids (Drugs)
Stroke
Stroke (Disease)
Vein & artery diseases
Viral infections
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELXQnrggWkANlGIQEnBIuxsnE5vbgqgKEiABRb1Fjh2XiCWJNruHfg8_ykzijWoJqRy4el6y2ZnxzDgZPzP2XICoMrAQC2fSmFJurBPpYkiMWmgptcxpN_LHT3B2nn64yC6uHfVFPWEjPfCouBNdYdIkihOn5mnppDKYkcEuMK0Z0GAo-mLO2y2mxhiMsxjAb5QT-eLE2-W4a5vqGLO8WmQiSEQDX_8UlWfdqu2DkjNsmLyWgU7vsju-dOTL8ZH32K2q2Wd7fnL2_KVnkH51j_0eOYl73jpOO4bqpue6sZxIEdra4njDDVEX6PUVH5o6r7j_UuNx6_ZnxeuGe9rVntP7Wk7cEmtqLkCn5SsME8FV3Xb1a7ylwzV429f9a77kl-NT8W46KYwPlLb32fnpu29vz2J_GkNsANQmBiilcc5KqOZK2rKUmbI45StMb6lVRoq5w_F8jrgFSVRWQZk7sLbEISkesFmD-j9gHBMnOChtacok1ZnTQmMZpwAXxfgTcxExsTNNYTxVOZ2YsSqG7285LllGlRdk0MIbNGLxdFU3UnXcgH9DVp-wRLQ9DKD7Fd79ipvcL2JPyGeKcdfqFC6KJUhqDMD6N2LPBgSRbTTUzXOpt31fvP_8_R9AX78EoBce5FpUh9F-BwX-JyLxCpCHARJDhgnEB-ThO630RZJJUCgFiVfuvP7v4qeTmG5KHXpN1W4HTJ5nuJjPI5YHsyVQcChp6h8Dozmx6qUCHv4PizxitxPqO8L6IskP2Wyz3laPsXDclEdDjPgDXZZv7Q
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELagXLggloe2yy4YhAQcstvmMba5oIJYLUiABCzqLXLsuFSUJDTtYX_P_lFmEjdgCQFX-3MeHs_D9vgzY48TSMoMLESJM2lELjfSsXQRxEZNtZRaCjqN_O49nJ2nb-fZ3C-4tT6tcmcTO0Nta0Nr5CdxJkFJtLfyRfMjolujaHfVX6FxlV0j6jJK6RLzYcKFugzgj8slYnripXPc1FV5jL5eTbMkcEcda_9gm0fNqm6DwDNMm_zND53eZDd8AMlnvcT32JWyusX2vIq2_KnnkX52m132zMQtrx2nc0PLquW6spyoEeqlxfKKGyIw0OsL3qV2XnC_X-Nx6_pbyZcV9-SrLadVW04ME2tKMcChy1doLIJWzXb1vX-kw5l43S7b53zGF_1X8Wa4L4x3xLZ32Pnp68-vziJ_J0NkANQmAiikcc5KKCdK2qKQmbKo-CU6udQqI5OJw3IxQdyUalRWQiEcWFtgkUzuslGF_b_POLpPcFDYwhRxqjOnE43BnAKcGuMrJsmYJTvR5MYTltO9Gau824UTOHHpuzwngeZeoGMWDa2anrDjH_iXJPUBS3TbXUG9XuRee3NdYuRGPDtOTdLCSWUwLAQ7xdjKgAYzZg9ozOT92dXBaOQzkJQegFHwmD3qEES5UVFOz0Jv2zZ_8-HLf4A-fQxATzzI1dgdRvtzFPhPROUVIA8DJBoOE1Tv0wjf9Uqb_1IxbLkb9X-ufjhU00MpT68q622HESLDKb0YMxFoS9DBYU21_NrxmhO3XprAwd9ffo9djymvCOOHWByy0Wa9LY8wMNwU9zvt_wn5TGhE
  priority: 102
  providerName: ProQuest
Title Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study
URI https://www.proquest.com/docview/2586980368
https://www.proquest.com/docview/2587752497
https://pubmed.ncbi.nlm.nih.gov/PMC8550436
https://doaj.org/article/ae0648014f904bf89c2516d1223c6a6c
http://dx.doi.org/10.1371/journal.pone.0259153
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELe27oUXxPjQOkYxCAl4SJVP20FCqJtaBtIGGhT1LXKcuFSUpCStRF_4Z_hHuXPciEhDwEsefGc3Pfs-HJ9_R8iTgAV5xDLmBFqFDrpcR_pCO8xXsSeFkILjbeSLS3Y-Dd_Ootke2dVstQKsr93aYT2pabUcfv-2fQUK_9JUbeDertNwVRb5EHx4DFq8Tw7AN3FU1YuwPVcA7Tanlxi1wOu4gb1M96dROs7KYPq3lru3WpZ1JyztJlX-5qUmt8hNG17SUbMeDsleXtwmh1aBa_rMokw_v0N-NrjFNS01xVtFi6KmssgoAieUiwzaC6oQ3kBWW2oSP7fUnuZYvqr8ktNFQS00a03xmy5F_IkKExBgYdMlmJJOr9Vm-bUZUsM-vawX9Qs6ovPmreiqrSZGDeztXTKdjD-enTu2YoOjGIvXDmOpUFpnguVuLLI0FVGcgVnIwQWGWaxE4Gpo5y7weUiJo5ylXLMsS6FJBPdIrwD5HxEKzpVplmapSv1QRloGEkK9mMHGGX7CDfok2E1NoiycOVbVWCbmjI7DtqYReYITmtgJ7ROn7bVq4Dz-wn-Ks97yIhi3aSireWJ1O5E5xHWIwqNjN0y1iBUEjSzzIPJSTDLVJw9xzSTNzdbWpCQjJjB5AGLkPnlsOBCQo8CMn7nc1HXy5t2nf2D6cNVhemqZdAniUNLesoD_hEBfHc6TDieYFdUhH-EK30mlTvxIsBioTEDP3aq_nvyoJeOgmMVX5OXG8HAewYaf9wnvaEtHwF1KsfhsUM8ReS8M2PF_zuB9csPHNCQIN3x-QnrrapM_gDhynQ7IPp9xeIozD5-T1wNycDq-fH81MF9mBsZ04PPH-BfOhHxq
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWcoALYnloyy6sQSDgkN00D8dGQqg8Vi37QIJd1Ftw7LhbUZLQtEL9Pdz5jcwkTiASAi57tcdJ6xl_Hscz3xDy0Gd-GjLNHN-owMEt15EeNw7zlBhIziWPMBv5-ISNzoK3k3CyQX40uTAYVtlgYgXUOlf4jXzfCzkTHPCWvyi-Olg1Cm9XmxIatVkcputvcGQrn49fg34fed7Bm9NXI8dWFXAUY2LpMJZwZYzmLHUF10nCQ6HBdFOA6UALxX3XQHvkgtwAe0SYsiQyTOsEmrgPz71ELsPG6-KKiibtAQ-wgzGbnudHg31rDXtFnqV74FuIQeh3tr-qSkC7F_SKeV52HN1umOZv-97BdXLNOqx0WFvYJtlIsxtk00JCSZ9Y3uqnN8n3mgm5pLmhmKc0y0oqM02RiiGfaWjPqELCBLlY0yqUdE3t_ZCVW-SfUzrLqCV7LSl-JabIaLHAkAZYKnQO4NQZVazmX-pHGjj55-WsfEaHdFr_Klq09cloRaR7i5xdiLZuk14G879FKGzXzLBEJyrxAhka6UtwHgWDozi8wvX7xG9UEytLkI51OuZxdesXwUGpnvIYFRpbhfaJ044qaoKQf8i_RK23skjvXTXki2ls0SKWKXiKyOtjhBskhgsFbijTA_DlFJNM9cku2kxc58q2IBUPGcdwBPC6--RBJYEUHxnGEE3lqizj8buP_yH04X1H6LEVMjlMh5I2bwP-E1KHdSR3OpIAVKrTvYUW3sxKGf9a0jCysfo_d99vu_GhGBeYpfmqkomi0AtE1CdRZ7V0Jrjbk83OKx515PILfHbn7y_fJVdGp8dH8dH45HCbXPUwpgl8Fy_aIb3lYpXeBad0mdyrkICSTxcNPT8BSXilXQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGkRAviPFHKwxmEAh4yNrEiWMjIVQY1cpgINhQ34LjxKWiJKFphfp5-BZ8Ou4SJxAJAS97tc9O4jv_fI7vfibkHuMsDXjCHWa07-CS6yhPGId7WrpKCCVCzEZ-fcwPT_2X02C6RX40uTAYVtlgYgXUSa7xH_nACwSXAvBWDIwNi3h7MH5afHXwBik8aW2u06hN5CjdfIPtW_lkcgC6vu954xcnzw8de8OAozmXK4fzWGhjEsHToRRJHItAJmDGKUC2n0gt2NBAeTgEORdrZJDyODQ8SWIoEgz6PUfOhyxwcY6F03azBzjCuU3VY6E7sJaxX-RZug9-hnQD1lkKqxsD2nWhVyzysuP0dkM2f1sDx5fJJeu80lFtbdtkK82ukG0LDyV9aDmsH10l32tW5JLmhmLO0jwrqcoSirQM-TyB8oxqJE9Qyw2twko31J4VWbll_jml84xa4teS4h9jiuwWSwxvgGlDFwBUnVbFevGl7tLMY_jmefmYjuisfitatHeV0YpU9xo5PRNtXSe9DMZ_h1BYurnhcRLr2PNVYBRT4EhKDttyeMSQ9QlrVBNpS5aOd3YsouoEMIRNUz3kESo0sgrtE6dtVdRkIf-Qf4Zab2WR6rsqyJezyCJHpFLwGpHjx8ihHxshNbikPHHBr9Nccd0ne2gzUZ032wJWNOICQxPAA--Tu5UE0n1kOHFmal2W0eTNh_8Qev-uI_TACpkchkMrm8MB34Q0Yh3J3Y4kgJbuVO-ghTejUka_pje0bKz-z9V32mrsFGMEszRfVzJhGHi-DPsk7MyWzgB3a7L5p4pTHXn9fMZv_P3he-QCgE70anJ8dJNc9DC8CdwYL9wlvdVynd4C_3QV366AgJKPZ408PwHKy6mT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+statins+and+steroids+on+coronary+artery+disease+and+stroke+in+patients+with+interstitial+lung+disease+and+pulmonary+fibrosis%3A+A+general+population+study&rft.jtitle=PloS+one&rft.au=Yeh%2C+Jun-Jun&rft.au=Lin%2C+Cheng-Li&rft.au=Hsu%2C+Nai-Hua&rft.au=Kao%2C+Chia-Hung&rft.date=2021-10-27&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=16&rft.issue=10&rft.spage=e0259153&rft_id=info:doi/10.1371%2Fjournal.pone.0259153&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0259153
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon